No Data
No Data
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
Craig-Hallum Sticks to Its Buy Rating for Ironwood Pharma (IRWD)
Is Ironwood Pharmaceuticals, Inc. (IRWD) the Best Small Cap Pharma Stocks to Buy Now?
IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down
A Quick Look at Today's Ratings for Ironwood Pharmaceuticals(IRWD.US), With a Forecast Between $3 to $14